Anti-coagulants are typically used after which events?

Anti-coagulants are primarily used in the management and prevention of thromboembolic events, particularly following myocardial infarction (MI) and stroke. These conditions are characterized by the formation of blood clots that can obstruct blood vessels, leading to serious complications. After an MI, the heart muscle can sustain damage, and there is a heightened risk of additional clot formation, which can lead to further cardiac events. Similarly, in the case of a stroke, especially an ischemic stroke caused by a blood clot, administering anticoagulants can help prevent subsequent strokes by inhibiting further clot development.

While other events such as head trauma, surgery, and infections may also involve considerations of coagulation and bleeding risk, the specific use of anticoagulants is most strongly indicated in the context of myocardial infarction and stroke to manage and prevent additional thrombotic events.